Delusions associated with elevated muscarinic binding in dementia with Lewy bodies
暂无分享,去创建一个
E. Perry | I. McKeith | J. O'Brien | N. Cairns | C. Holmes | E. Jaros | R. Perry | M. Piggott | C. Ballard | Mary Johnson | M Johnson | I McKeith | C Ballard | J O'Brien | C Holmes | N Cairns | R Perry | E Jaros | E Perry | M Piggott | J. O’Brien
[1] I. McKeith,et al. Neuroleptic sensitivity to risperidone in Lewy body dementia , 1995, The Lancet.
[2] Hans Förstl,et al. Psychotic features and the course of Alzheimer's disease: relationship to cognitive, electroencephalographic and computerized tomography findings , 1993, Acta psychiatrica Scandinavica.
[3] I. McKeith,et al. Simple Standardised NeuropsychologicalAssessments Aid in the Differential Diagnosis of Dementia with Lewy Bodies from Alzheimer’s Disease and Vascular Dementia , 1999, Dementia and Geriatric Cognitive Disorders.
[4] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[5] K Ugurbil,et al. Activation of visuomotor systems during visually guided movements: a functional MRI study. , 1998, Journal of magnetic resonance.
[6] D. Bennett,et al. Hallucinations and associated factors in Alzheimer's disease. , 1991, The Journal of neuropsychiatry and clinical neurosciences.
[7] P. Ince,et al. The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies , 1997, Acta neurologica Scandinavica.
[8] J. Pearce. Longus cervicis colli "myositis" (syn: retropharyngeal tendinitis) , 1996, Journal of neurology, neurosurgery, and psychiatry.
[9] Mary Johnson,et al. Autoradiographic comparison of cholinergic and other transmitter receptors in the normal human hippocampus , 1993, Hippocampus.
[10] Wayne C. Drevets,et al. Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type , 1989, Biological Psychiatry.
[11] C. Ballard,et al. Paranoid features in the elderly with dementia , 1991 .
[12] G. Stebbins,et al. Intravenous levodopa in hallucinating Parkinson's disease patients , 1998, Neurology.
[13] Mrinalini Honavar,et al. Lewy bodies and response to tacrine in Alzheimer's disease , 1994, The Lancet.
[14] P V Rabins,et al. The impact of dementia on the family. , 1982, JAMA.
[15] L. Schneider,et al. Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease. , 1994, Archives of neurology.
[16] Organic delusions: phenomenology, anatomical correlations, and review. , 1985, The British journal of psychiatry : the journal of mental science.
[17] A. Kurz,et al. DELUSIONS AND HALLUCINATIONS IN ALZHEIMER'S DISEASE: RESULTS FROM A TWO‐YEAR LONGITUDINAL STUDY , 1996 .
[18] J. R. Baker,et al. The hippocampal formation participates in novel picture encoding: evidence from functional magnetic resonance imaging. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[19] D. Jeste,et al. Cognitive deficits of patients with Alzheimer's disease with and without delusions. , 1992, The American journal of psychiatry.
[20] Robert H. Perry,et al. Senile dementia of Lewy body type A clinically and neuropathologically distinct form of Lewy body dementia in the elderly , 1990, Journal of the Neurological Sciences.
[21] E. Perry,et al. Convergent cholinergic activities in aging and Alzheimer's disease , 1992, Neurobiology of Aging.
[22] J. Moossy,et al. Neuropathologic and neurochemical correlates of psychosis in primary dementia. , 1991, Archives of neurology.
[23] E. Perry,et al. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. , 1992, BMJ.
[24] D. Wong,et al. Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232). , 1994, The Journal of pharmacology and experimental therapeutics.
[25] K. Marder,et al. The Columbia University Scale for Psychopathology in Alzheimer's disease. , 1992, Archives of neurology.
[26] M. Olianas,et al. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor , 1997, British journal of pharmacology.
[27] E. Perry,et al. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. , 1999, The American journal of psychiatry.
[28] B. Gulanski,et al. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease , 1998, Neurology.
[29] G. Wilcock,et al. The prevalence and phenomenology of psychotic symptoms in dementia sufferers , 1995 .
[30] J. Copeland,et al. Computerized diagnosis from a standardized history schedule: A preliminary communication about the organic section of the HAS–AGECAT system , 1992 .
[31] P. Hedera,et al. Delirium in Alzheimer Disease , 1997, Alzheimer disease and associated disorders.
[32] E. Richelson,et al. Muscarinic m4 receptor activation by some atypical antipsychotic drugs. , 1997, European journal of pharmacology.
[33] H. Haeske-Dewick. Hallucinations in Parkinson's disease: Characteristics and associated clinical features , 1995 .
[34] Abraham Weizman,et al. Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease. , 1996, Advances in neurology.
[35] C. Tanner,et al. Early dopaminergic drug-induced hallucinations in parkinsonian patients , 1998, Neurology.
[36] J. Grace,et al. Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease , 1998, The Lancet.
[37] M. Hutchinson,et al. Cholinesterase inhibition in Parkinson's disease. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[38] D. Bass,et al. Symptoms of mental impairment among elderly adults and their effects on family caregivers. , 1986, Journal of gerontology.
[39] A. Burns,et al. Psychiatric Phenomena in Alzheimer's Disease. I: Disorders of Thought Content , 1990, British Journal of Psychiatry.
[40] K. Rockwood,et al. Donepezil for Treatment of Dementia With Lewy Bodies: A Case Series of Nine Patients , 1998, International Psychogeriatrics.
[41] F. Huppert,et al. CAMDEX: A Standardised Instrument for the Diagnosis of Mental Disorder in the Elderly with Special Reference to the Early Detection of Dementia , 1986, British Journal of Psychiatry.
[42] E. Perry,et al. Evidence of a Monoaminergic‐Cholinergic Imbalance Related to Visual Hallucinations in Lewy Body Dementia , 1990, Journal of neurochemistry.
[43] G. Zubenko,et al. Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease , 1991, Biological Psychiatry.
[44] K. Kosaka,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.
[45] D. Jeste. Mechanisms of Drug Action on the Nervous System, 2nd ed , 1992 .
[46] S. Zorn,et al. Clozapine is a potent and selective muscarinic M4 receptor agonist. , 1994, European journal of pharmacology.
[47] R. Levy,et al. Neuropathological Correlates of Psychotic Phenomena in Confirmed Alzheimer's Disease , 1994, British Journal of Psychiatry.
[48] G A Chase,et al. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. , 1990, The American journal of psychiatry.